Related Experiment Video
Updated: Feb 7, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Long-term risk of stroke and bleeding post-atrial fibrillation ablation
Jacqueline Joza1, Michelle Samuel2, Cynthia A Jackevicius3,4,5
1Division of Cardiology, McGill University Health Centre and McGill Research Institute, Montreal, Canada.
Insights
Catheter ablation (CA) for atrial fibrillation (AF) did not show a significant reduction in stroke or major bleeding risk when accounting for oral anticoagulation (OAC) use. Continued OAC therapy post-CA is advised based on individual risk profiles.
Area of Science:
- Cardiology
- Medical Interventions
- Public Health
Background:
- Catheter ablation (CA) is a standard treatment for atrial fibrillation (AF).
- Real-world, long-term outcomes of CA often lack consistent analysis of oral anticoagulation (OAC) use.
- Understanding OAC patterns post-CA is crucial for evaluating treatment effectiveness.
Purpose of the Study:
- To analyze OAC usage patterns following CA in AF patients.
- To compare the OAC-adjusted risks of stroke and major bleeding in AF patients who underwent CA versus those who did not.
- To provide real-world data on the long-term efficacy and safety of CA in relation to OAC management.
Main Methods:
- A population-based cohort study in Canada (1999-2014) included AF patients.
- Propensity score matching was used to compare outcomes between CA and non-CA groups.
- Time-dependent OAC use was factored into the analysis of stroke and major bleeding incidence.
Main Results:
- 6,391 patients underwent CA, compared to 482,977 controls; 1,240 CA patients were matched with 2,427 controls.
- OAC persistence post-CA was 78% at 1 year, decreasing to 61% by 5 years.
- No significant difference in stroke (aHR=0.88) or major bleeding (aHR=0.88) risk was observed between groups when adjusted for OAC.
Conclusions:
- CA did not significantly reduce stroke or major bleeding risk when OAC use was considered over time.
- Discontinuing OAC post-CA is not supported by current evidence; continued anticoagulation based on risk is recommended.
- Further randomized trials are needed to confirm CA's stroke reduction benefits and the safety of OAC discontinuation.
Background:
Catheter ablation (CA) is an established therapy for atrial fibrillation (AF). Studies regarding long-term real-world outcomes post-CA have inconsistently accounted for oral anticoagulation (OAC).
Objectives:
To describe patterns of OAC use post-CA and to compare the OAC-adjusted long-term risk of stroke and major bleeding in AF patients with and without CA.
Methods:
A population-based cohort of AF patients was constructed in Quebec and Ontario, Canada (1999-2014). Propensity score matching was performed to determine the incidence rates of stroke and major bleeding among those undergoing CA, adjusted for time-dependent OAC use.
Results:
From the entire cohort, 6391 patients were identified as having undergone CA as compared to 482 977 patients who did not. Of these, 1240 patients with government medical insurance undergoing CA were matched with 2427 patients without CA. Post-CA, 78%, 65%, and 61% remained on an OAC at 1, 2, and 5 years, while 75%, 71%, and 68% of patients not undergoing CA were on OACs at 1, 2, and 5 years. At follow-up, there was no statistically significant difference for stroke (adjusted hazard ratio [HR], 0.88; 95% CI, 0.63 to 1.21) or major bleeding (adjusted HR, 0.88; 95% CI, 0.73 to 1.06).
Conclusion:
No evidence was found that CA significantly decreases the risk of stroke or major bleeding when adjusting for OAC use over time. It may be prudent to continue anticoagulation post-CA based on patient-risk profile until randomized trials demonstrate both reduced stroke rates with CA, and improved safety (balancing stroke and bleeding risk) with OAC discontinuation post-CA.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Bleeding in Fresh Concrete
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Relative Risk
Long-term Depression

